VeonGen Therapeutics, formerly known as ViGeneron, announced its rebranding to reflect its evolution into a clinical-stage genetic medicine company focused on developing transformative gene...
Alcon has announced the U.S. Food and Drug Administration (FDA) has approved TRYPTYR® (acoltremon ophthalmic solution) 0.003%, formerly known as AR-15512, for the treatment...